Loading…
Transcriptional Profiling of a Cross-Protective Salmonella enterica serovar Typhimurium UK-1 dam Mutant Identifies a Set of Genes More Transcriptionally Active Compared to Wild-Type, and Stably Transcribed across Biologically Relevant Microenvironments
Vaccination with serovar Typhimurium lacking DNA adenine methyltransferase confers cross-protective immunity against multiple serotypes. The mechanistic basis is thought to be associated with the de-repression of genes that are tightly regulated when transiting from one microenvironment to another....
Saved in:
Published in: | Pathogens (Basel) 2014-05, Vol.3 (2), p.417-436 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Vaccination with
serovar Typhimurium lacking DNA adenine methyltransferase confers cross-protective immunity against multiple
serotypes. The mechanistic basis is thought to be associated with the de-repression of genes that are tightly regulated when transiting from one microenvironment to another. This de-repression provides a potential means for the production of a more highly expressed and stable antigenic repertoire capable of inducing cross-protective immune responses. To identify genes encoding proteins that may contribute to cross-protective immunity, we used a
Typhimurium DNA adenine methyltransferase mutant strain (UK-1
mutant) derived from the parental UK-1 strain, and assessed the transcriptional profile of the UK-1
mutant and UK-1 strain grown under conditions that simulate the intestinal or endosomal microenvironments encountered during the infective process. As expected, the transcriptional profile of the UK-1
mutant identified a set of genes more transcriptionally active when compared directly to UK-1, and stably transcribed in biologically relevant culture conditions. Further, 22% of these genes were more highly transcribed in comparison to two other clinically-relevant
serovars. The strategy employed here helps to identify potentially conserved proteins produced by the UK-1
mutant that stimulate and/or modulate the development of cross-protective immune responses toward multiple
serotypes. |
---|---|
ISSN: | 2076-0817 2076-0817 |
DOI: | 10.3390/pathogens3020417 |